Year archive

ISLAND PHARMACEUTICALS LIMITED — 2024 filings

All 119 regulatory filings released by ISLAND PHARMACEUTICALS LIMITED (ILA) in 2024, sourced directly from the official regulator.

119 Filings

2024 Period

2024 filings (119)

Filing	Released	Lang
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2024-12-23	English
Letter to Shareholders, Notice of EGM & Proxy Form 19 pages 400.0KB AGM Information	2024-12-19	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2024-12-17	English
Notification regarding unquoted securities - ILA 6 pages 19.6KB Share Issue/Capital Change	2024-12-16	English
Change of Director's Interest Notice x 2 (CN & DF) 7 pages 344.6KB Director's Dealing	2024-12-16	English
US patent granted for ISLA-101 2 pages 139.9KB Regulatory Filings	2024-12-10	English
Change in substantial holding 3 pages 323.3KB Major Shareholding Notification	2024-12-09	English
Change of Director's Interest Notice (CN) 3 pages 335.9KB Director's Dealing	2024-12-04	English
Change in substantial holding 2 pages 168.4KB Major Shareholding Notification	2024-12-04	English
Application for quotation of securities - ILA 6 pages 18.5KB Share Issue/Capital Change	2024-12-03	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-12-03	English
Notification regarding unquoted securities - ILA 8 pages 26.6KB Share Issue/Capital Change	2024-12-03	English
Cleansing Notice 1 page 406.9KB Capital/Financing Update	2024-12-03	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-12-03	English
Change in substantial holding 2 pages 134.8KB Major Shareholding Notification	2024-12-03	English
EGM (Spill Meeting) & Closing Date for Director Nominations 2 pages 85.2KB Board/Management Information	2024-12-02	English
Scientific Advisory Board Change 2 pages 159.7KB Board/Management Information	2024-12-01	English
ISLA-101 shows anti-dengue activity in Phase 2a readout 5 pages 221.2KB Capital/Financing Update	2024-11-26	English
Island Phase 2a readout investor briefing 2 pages 139.4KB Investor Presentation	2024-11-26	English
Island Phase 2a readout investor briefing presentation 12 pages 2.2MB Investor Presentation	2024-11-26	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-11-26	English
Trading Halt 2 pages 248.3KB Regulatory Filings	2024-11-24	English
Receipt of R&D tax refund for FY2024 2 pages 139.2KB Capital/Financing Update	2024-11-21	English
Final Director's Interest Notice x 2 4 pages 302.3KB Director's Dealing	2024-11-20	English
Initial Director's Interest Notice - PL 2 pages 256.1KB Director's Dealing	2024-11-20	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-11-19	English
Annual General Meeting MD Presentation 24 pages 2.5MB Investor Presentation	2024-11-18	English
Results of AGM 2 pages 28.6KB Declaration of Voting Results & Voting Rights Announcements	2024-11-18	English
Replacement - Results of AGM 4 pages 189.8KB Declaration of Voting Results & Voting Rights Announcements	2024-11-18	English
Clinical trial progress update 2 pages 172.2KB Regulatory Filings	2024-11-17	English
Phillip Lynch appointed Executive Chairman 2 pages 440.2KB Board/Management Information	2024-11-14	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-11-12	English
Investor Presentation 29 pages 3.4MB Investor Presentation	2024-11-11	English
Board changes 2 pages 140.7KB Board/Management Information	2024-11-10	English
Investor information session 2 pages 420.2KB Investor Presentation	2024-11-06	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-11-05	English
Quarterly Activities & Cashflow Report 9 pages 382.8KB Interim / Quarterly Report	2024-10-30	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-10-29	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-10-22	English
Letter to Shareholders, Notice of AGM & Proxy Form 38 pages 695.8KB AGM Information	2024-10-17	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-10-15	English
Becoming a substantial holder 3 pages 710.2KB Major Shareholding Notification	2024-10-14	English
Change in substantial holding 3 pages 313.4KB Major Shareholding Notification	2024-10-14	English
Change in substantial holding 3 pages 248.2KB Major Shareholding Notification	2024-10-14	English
Becoming a substantial holder 3 pages 338.0KB Major Shareholding Notification	2024-10-14	English
Application for quotation of securities - ILA 6 pages 18.8KB Share Issue/Capital Change	2024-10-10	English
Cleansing Notice 1 page 192.6KB Capital/Financing Update	2024-10-10	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-10-08	English
Investor presentation 26 pages 2.3MB Investor Presentation	2024-10-07	English
Investor webinar 2 pages 163.7KB Investor Presentation	2024-10-03	English
Phase 2a PROTECT clinical trial dosed & Investor webinar 3 pages 180.8KB Capital/Financing Update	2024-10-02	English
Island completes $3.5m Placement 4 pages 235.9KB Capital/Financing Update	2024-10-02	English
Proposed issue of securities - ILA 7 pages 25.2KB Capital/Financing Update	2024-10-02	English
Trading Halt 2 pages 223.9KB Capital/Financing Update	2024-09-30	English
Initial Director's Interest Notice - CN 2 pages 250.3KB Director's Dealing	2024-09-22	English
Final Director's Interest Notice - DB 2 pages 274.0KB Director's Dealing	2024-09-22	English
Board changes 2 pages 173.0KB Board/Management Information	2024-09-18	English
Investor presentation 24 pages 1.8MB Investor Presentation	2024-09-18	English
Application for quotation of securities - ILA 6 pages 18.2KB Share Issue/Capital Change	2024-09-17	English
Binding LOI for proposed acquisition of Galidesivir 3 pages 223.9KB M&A Activity	2024-09-10	English
Preliminary Final Report 2 pages 256.1KB Earnings Release	2024-08-28	English
Annual Report to shareholders 60 pages 4.4MB Regulatory Filings	2024-08-28	English
Appendix 4G and Corporate Governance Statement 28 pages 732.1KB Regulatory Filings	2024-08-28	English
Phase 2a/b clinical trial update 3 pages 220.5KB Capital/Financing Update	2024-08-26	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2024-08-06	English
ISLA-101 Phase 2a/b clinical trial progresses 3 pages 919.5KB Capital/Financing Update	2024-08-06	English
Quarterly Activities & Cashflow Report 8 pages 459.9KB Interim / Quarterly Report	2024-07-30	English
Resignation of Joint Company Secretary 2 pages 147.9KB Board/Management Information	2024-07-18	English
Investor Presentation - Bioshares 22 pages 2.1MB Investor Presentation	2024-07-09	English
Non-binding term sheet signed with BioCryst 5 pages 221.0KB Capital/Financing Update	2024-07-02	English
ISLA-101 Clinical Program Update 3 pages 173.3KB Regulatory Filings	2024-07-02	English
Trading Halt 2 pages 577.6KB Regulatory Filings	2024-06-30	English
Application for quotation of securities - ILA 6 pages 18.3KB Share Issue/Capital Change	2024-06-25	English
Change of Director Interest Notice - DF 3 pages 226.7KB Director's Dealing	2024-06-25	English
Application for quotation of securities - ILA 6 pages 19.1KB Share Issue/Capital Change	2024-06-20	English
Change in substantial holding 3 pages 310.2KB Major Shareholding Notification	2024-06-20	English
Application for quotation of securities - ILA 6 pages 18.5KB Share Issue/Capital Change	2024-06-18	English
Application for quotation of securities - ILA 6 pages 18.4KB Share Issue/Capital Change	2024-06-11	English
Notification regarding unquoted securities - ILA 7 pages 21.8KB Share Issue/Capital Change	2024-06-05	English
Piggy Back Options Closing Date Reminder 2 pages 175.0KB Capital/Financing Update	2024-06-05	English
Application for quotation of securities - ILA 6 pages 18.4KB Share Issue/Capital Change	2024-06-04	English
New data leads to proposed ISLA-101 Phase 2 efficiencies 4 pages 669.3KB Capital/Financing Update	2024-06-02	English
Investor Presentation 27 pages 3.4MB Investor Presentation	2024-06-02	English
Application for quotation of securities - ILA 6 pages 18.4KB Share Issue/Capital Change	2024-05-28	English
Grant funding to directly support Phase 2a trial 2 pages 174.8KB Capital/Financing Update	2024-05-07	English
Notification of cessation of securities - ILA 6 pages 20.1KB Regulatory Filings	2024-05-05	English
Change of Director's Interest Notice x5 15 pages 388.9KB Director's Dealing	2024-05-05	English
Quarterly Appendix 4C and Activities Report 8 pages 428.0KB Interim / Quarterly Report	2024-04-29	English
Investor Presentation - Asia Bio Partnering 24 pages 3.0MB Investor Presentation	2024-04-21	English
Application for quotation of securities - ILA 6 pages 18.6KB Share Issue/Capital Change	2024-04-16	English
Positive data from ISLA-101 Single Ascending Dose study 3 pages 163.7KB Regulatory Filings	2024-04-15	English
Change of Director's Interest Notice x 5 15 pages 400.4KB Director's Dealing	2024-04-03	English
Change in substantial holding 3 pages 159.9KB Major Shareholding Notification	2024-04-03	English
Change in substantial holding 3 pages 119.4KB Major Shareholding Notification	2024-04-03	English
Change in substantial holding 3 pages 310.8KB Major Shareholding Notification	2024-04-02	English
Security Class Reinstatement to Quotation ILAO 1 pa Regulatory Filings	2024-04-01	English
Top 20 Option Holders & Distribution Schedule 3 pages 90.2KB Major Shareholding Notification	2024-04-01	English
Application for quotation of securities - ILA 6 pages 19.8KB Share Issue/Capital Change	2024-03-26	English
Updated Trading Policy 10 pages 289.0KB Regulatory Filings	2024-03-26	English
Application for quotation of securities - ILA 6 pages 20.0KB Capital/Financing Update	2024-03-25	English
Security Class Suspension from Quotation ILAO 1 pag Regulatory Filings	2024-03-25	English
Update - Proposed issue of securities - ILA 8 pages 29.9KB Capital/Financing Update	2024-03-20	English
Results of Rights Issue Offer 3 pages 92.5KB Capital/Financing Update	2024-03-18	English
Letter to ineligible shareholders 2 pages 147.4KB Capital/Financing Update	2024-03-04	English
Despatch of Rights Issue documentation 2 pages 148.9KB Capital/Financing Update	2024-03-04	English
Appendix 4D & Half-Year Financial Statements 19 pages 1.0MB Interim / Quarterly Report	2024-02-25	English
$1.95million Fully Underwritten Rights Issue 5 pages 171.8KB Capital/Financing Update	2024-02-25	English
Prospectus 62 pages 990.9KB Capital/Financing Update	2024-02-25	English
Proposed issue of securities - ILA 8 pages 30.1KB Capital/Financing Update	2024-02-25	English
Target Market Determination 6 pages 194.9KB Regulatory Filings	2024-02-25	English
Letter to Eligible Shareholders 2 pages 241.7KB Capital/Financing Update	2024-02-25	English
Letter to Optionholders 2 pages 228.5KB Capital/Financing Update	2024-02-25	English
Update - Proposed issue of securities - ILA 8 pages 29.7KB Capital/Financing Update	2024-02-25	English
Trading Halt 2 pages 216.1KB Capital/Financing Update	2024-02-21	English
Dosing complete in ISLA-101 SAD study 2 pages 157.5KB Capital/Financing Update	2024-02-05	English
Island investor presentation 24 pages 2.1MB Investor Presentation	2024-02-05	English
Quarterly Activity Report and Appendix 4C 8 pages 404.6KB Interim / Quarterly Report	2024-01-30	English
Third cohort dosed in ISLA-101 Single Ascending Dose study 2 pages 157.3KB Regulatory Filings	2024-01-18	English
Notification of cessation of securities - ILA 4 pages 24.0KB Share Issue/Capital Change	2024-01-10	English